ArticleScience immunology2020

Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes.

Tianshi Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.